Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Flumazenil for Hypnotic Reversal
NCT01071889Phase 2Completed
- Sponsor
- coeruleus
- Start
- May 2010
- Primary completion
- Aug 2012
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of flumazenil, sponsored by coeruleus. Started May 2010; status: completed.
02
Drugs
flumazenil
Beyond the preview
Go deeper on NCT01071889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071889.